Business Description
Genomtec SA
ISIN : PLGNMTC00017
Total Employee Number:
22Description
Genomtec SA is an technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.4 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -0.29 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.82 | |||||
Beneish M-Score | 2.47 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -37 | |||||
3-Year EBITDA Growth Rate | 25.9 | |||||
3-Year EPS without NRI Growth Rate | 18.1 | |||||
3-Year FCF Growth Rate | 4.2 | |||||
3-Year Book Growth Rate | 5.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.65 | |||||
9-Day RSI | 46.79 | |||||
14-Day RSI | 45.24 | |||||
3-1 Month Momentum % | 7.12 | |||||
6-1 Month Momentum % | 30.66 | |||||
12-1 Month Momentum % | -28.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.77 | |||||
Quick Ratio | 1.77 | |||||
Cash Ratio | 0.62 | |||||
Days Sales Outstanding | 22871.81 | |||||
Days Payable | 26.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.2 | |||||
Shareholder Yield % | 1.29 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -27731.25 | |||||
Operating Margin % | -28825 | |||||
Net Margin % | -29443.75 | |||||
EBITDA Margin % | -19762.5 | |||||
FCF Margin % | -30293.75 | |||||
OCF Margin % | -30209.38 | |||||
ROE % | -86.2 | |||||
ROA % | -53.69 | |||||
ROIC % | -89.59 | |||||
3-Year ROIIC % | 82.7 | |||||
ROC (Joel Greenblatt) % | -377.48 | |||||
ROCE % | -68.24 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4795 | |||||
PB Ratio | 10.3 | |||||
Price-to-Tangible-Book | 22.83 | |||||
EV-to-EBIT | -7.74 | |||||
EV-to-EBITDA | -11.3 | |||||
EV-to-Revenue | 2234.09 | |||||
EV-to-FCF | -7.23 | |||||
| Price-to-Net-Current-Asset-Value | 53.28 | |||||
Earnings Yield (Greenblatt) % | -12.92 | |||||
FCF Yield % | -13.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genomtec SA Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 0.032 | ||
| EPS (TTM) (zł) | -0.62 | ||
| Beta | -0.7456 | ||
| 3-Year Sharpe Ratio | -0.33 | ||
| 3-Year Sortino Ratio | -0.51 | ||
| Volatility % | 61.17 | ||
| 14-Day RSI | 45.24 | ||
| 14-Day ATR (zł) | 0.312852 | ||
| 20-Day SMA (zł) | 4.90875 | ||
| 12-1 Month Momentum % | -28.56 | ||
| 52-Week Range (zł) | 3.245 - 7.33 | ||
| Shares Outstanding (Mil) | 15.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genomtec SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genomtec SA Stock Events
| Event | Date | Price (zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genomtec SA Frequently Asked Questions
What is Genomtec SA(WAR:GMT)'s stock price today?
The current price of WAR:GMT is zł4.80. The 52 week high of WAR:GMT is zł7.33 and 52 week low is zł3.25.
When is next earnings date of Genomtec SA(WAR:GMT)?
The next earnings date of Genomtec SA(WAR:GMT) is .
Does Genomtec SA(WAR:GMT) pay dividends? If so, how much?
Genomtec SA(WAR:GMT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Genomtec SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers